Ependymal Tumor — Clinical Trials

MONDO:00032663 active·2 recruitingLast updated: Mar 19, 2026, 4:49 AM

Trial Landscape

Ependymal Tumor has an emerging clinical trial program, driven by drug treatment and gene therapy.

Recruiting

Active Trials

By Approach

Drug Treatment2

Gene Therapy1

Procedure1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

Phase 2

Sponsor Types

Academic/Other2NIH1

Trial Locations

United States3 trials

Puerto Rico1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT07226453

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Sponsor:University of California, San Francisco

United StatesStarted: Mar 2026Est. completion: Mar 2030Updated: Mar 2026

Phase 1Recruiting

NCT04099797

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Sponsor:Baylor College of Medicine

United StatesStarted: Feb 2020Est. completion: Feb 2041Updated: Sep 2025

Phase 2Active, Not Recruiting

NCT03698994

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Nov 2018Est. completion: Mar 2026Updated: Dec 2025

Stay informed about clinical trials for Ependymal Tumor.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 4:49 AM